Inventor · disambiguated record
Arwed Cleve
Also filed as: CLEVE ARWED
25 granted patents·12 pending applications·336 citations·filing 1991–2024
96Inventor score
Top patents by PatentIndex Score
37 records- 0192US9315509B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELTAXSYS INC·Filed 2014·Granted Apr 19, 2016·17 cites·20 claims
- 0292US7737145B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseESTRELLITA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·32 cites·10 claims
- 0391US6316432B1Antigestagenically active steroids with a flourinated 17 α-alkyl chainSCHERING AG·Filed 2000·Granted Nov 13, 2001·40 cites·34 claims
- 0490US11267819B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 0590US8569303B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseARNAIZ DAMIAN O·Filed 2010·Granted Oct 29, 2013·19 cites·12 claims
- 0688US10844016B2Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2017·Granted Nov 24, 2020·7 cites·15 claims
- 0788US2025296935A1Diamine Derivatives as Inhibitors of Leukotriene A4 HydrolaseCELLTAXIS LLC·Filed 2024·Application pending·0 cites
- 0887US6503895B2Antigestagenically active steroids with a fluorinated 17α-alkyl chainSCHERING AG·Filed 2001·Granted Jan 7, 2003·22 cites·25 claims
- 0985US7148213B2Antigestagenically active steroids with a fluorinated 17α-alkyl chainSCHERING AG·Filed 2004·Granted Dec 12, 2006·18 cites·27 claims
- 1085US6806263B2Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chainSCHERING AG·Filed 2002·Granted Oct 19, 2004·17 cites·25 claims
- 1182US8053426B2Progesterone receptor antagonistsBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 8, 2011·12 cites·28 claims
- 1281US12173009B2Diamine derivatives as inhibitors of leukotriene A4 hydrolaseCELLTAXIS LLC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 1380US7910573B2Crystalline forms of 11β-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-oneBAYER SCHERING PHARMA AG·Filed 2007·Granted Mar 22, 2011·12 cites·11 claims
- 1477US6861432B2Piperazine derivatives that destabilize androgen receptorsSCHERING AG·Filed 2002·Granted Mar 1, 2005·11 cites·20 claims
- 1572US5843933A11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Dec 1, 1998·31 cites·34 claims
- 1667US5426102A14β-H-, 14-and 15-En-11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Jun 20, 1995·20 cites·3 claims
- 1766US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1866US5843931A6,7-modified 11β-aryl-4-oestrenesSCHERING AG·Filed 1991·Granted Dec 1, 1998·21 cites·4 claims
- 1965US2018230159A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2018·Application pending·0 cites
- 2063US5728689A11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1995·Granted Mar 17, 1998·18 cites·26 claims
- 2162US5405979AProcess for the production of 10β-H-steroidsSCHERING AG·Filed 1991·Granted Apr 11, 1995·15 cites·5 claims
- 2261US2013123243A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2012·Application pending·0 cites
- 2360US2016272649A1Diamine derivatives as inhibitors of leukotriene a4 hydrolaseCELTAXSYS INC·Filed 2016·Application pending·0 cites
- 2457US11524938B2Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2020·Granted Dec 13, 2022·0 cites·9 claims
- 2552US6767903B1New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseasesSCHERING AG·Filed 1999·Granted Jul 27, 2004·10 cites·14 claims
- 2644US2017037028A1Glucose transport inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2743US5519027AD-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agentsSCHERING AG·Filed 1991·Granted May 21, 1996·5 cites·7 claims
- 2842US2006111378A1Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agentsCLEVE ARWED·Filed 2005·Application pending·0 cites
- 2942US2007155727A1Amide inhibitors of leukotriene A4 hydrolaseSCHERING AKTIENGESSELLSCHAFT·Filed 2006·Application pending·0 cites
- 3039US5359054AInitial compounds for the production of 10β-H-steroids and a process for the production of these initial compoundsSCHERING AG·Filed 1991·Granted Oct 25, 1994·4 cites·3 claims
- 3135US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3235US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3335US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3432US2017210738A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3532US2017226081A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3630US6596713B1Steroid esters and amides, process for their production and their pharmaceutical useSCHERING AG·Filed 1997·Granted Jul 22, 2003·2 cites·21 claims
- 3730US6096732ASteroid esters, process for their production and their pharmaceutical useSCHERING AG·Filed 1997·Granted Aug 1, 2000·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Arwed Cleve files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →